Loading company…
Riskpilot
← Back to search
Sign in
Get full access
SENS AS
AS
Active
Org 916248326
Fornebuveien 40, 1366 Lysaker
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2015
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 0
EBITDA margin
—
-557% vs 2023
Equity ratio
26.6%
Financial strength
Net profit 2024
NOK 53K
+210% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 0
—
EBITDA
NOK -8K
-557%
Net profit
NOK 53K
+210%
Total assets
NOK 1,2M
+5%
Equity
NOK 312K
+20%
Employees
0
—
Company information
Legal name
SENS AS
Org number
916248326
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
18. november 2015
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Holdingselskap som finansierer datterselskaper samt investerer i fond.
Contact
Address
Fornebuveien 40, 1366 Lysaker
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Bærum
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
0
Staff expenses
−0
−0
−0
−0
−0
EBITDA
−11
0
−1
−1
−8
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−11
0
−1
−1
−8
Net financials
173
46
13
23
68
Profit before tax
161
46
12
22
60
Tax
−0
−2
6
5
7
Net profit
161
48
6
17
53
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
539
587
1 097
1 115
1 170
Equity
188
236
242
259
312
Long-term debt
351
351
851
851
851
Short-term debt
0
0
4
5
7
Total debt
351
351
855
856
858
Financial ratios
5-year trend
EBITDA margin
-753300.0%
This company
15.8%
Market median
-4767822% vs market
2020
2024
Equity ratio
26.6%
This company
38.2%
Market median
-30% vs market
2020
2024
Return on equity
17.0%
This company
18.4%
Market median
+8% vs market
2020
2024
Net profit margin
5294400.0%
This company
8.1%
Market median
+65362863% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
2.75×
This company
0.62×
Market median
-344% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
NG
Nikolai Gilhuus-Moe
Chairman
2015
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
SENS AS
(this company)
ARCTIC MEDICAL AS
Board network connections
Board members of SENS AS also hold positions in
0
other companies.
Person
Role here
Other companies
Nikolai Gilhuus-Moe
Chairman
0 companies